Noah Lechtzin, M.D., M.H.S.

Background

Descriptive text is not available for this image

  • Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine
  • Joint Appointment, Department of Neurology, Johns Hopkins University School of Medicine
  • Associate Director, Johns Hopkins Adult Cystic Fibrosis Program

Publications

  • 32 Peer Reviewed Articles
  • 17 chapters, letters, and reports

Education

  • M.D., Temple University School of Medicine
  • Internship and Residency, Johns Hopkins Hospital
  • M.H.S. Clinical Epidemiology, Johns Hopkins University Bloomberg School of Public Health
  • Fellowship in Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine

Societies

  • Fellow, American College of Chest Physicians
  • Member American Thoracic Society
  • Vice Chair, Home Care Section of the American College of Chest Physicians

Previous Appointments

  • Instructor, Department of Medicine, Johns Hopkins University School of Medicine

Research

  • Director Data Management and Statistics Core, Molecular Determinants of Pulmonary Hypertension
  • Investigator, Pivotal Study of NeuRx RA/4 for Motor-Point Stimulation for Conditioning the Diaphragm of Patients with Amyotrophic Lateral Sclerosis (ALS)
  • Principal Investigator, MULTIDOSE SAFETY AND TOLERABILITY STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE™) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA. Protocol No.:TR02-106

Disclosures

  • Consultant, Respironics, Inc.
  • Research Funding -Transave
  • Speaker, Hill-Rom inc.

Last updated: January 21, 2014